Anniella Isgren

543 total citations
13 papers, 368 citations indexed

About

Anniella Isgren is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Speech and Hearing. According to data from OpenAlex, Anniella Isgren has authored 13 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 5 papers in Biological Psychiatry and 4 papers in Speech and Hearing. Recurrent topics in Anniella Isgren's work include Bipolar Disorder and Treatment (11 papers), Tryptophan and brain disorders (5 papers) and Adolescent and Pediatric Healthcare (4 papers). Anniella Isgren is often cited by papers focused on Bipolar Disorder and Treatment (11 papers), Tryptophan and brain disorders (5 papers) and Adolescent and Pediatric Healthcare (4 papers). Anniella Isgren collaborates with scholars based in Sweden, United Kingdom and United States. Anniella Isgren's co-authors include Mikael Landén, Carl M. Sellgren, Joel Jakobsson, Henrik Zetterberg, Kaj Blennow, Erik Pålsson, Carl Johan Ekman, Jessica Holmén‐Larsson, Maria Bjerke and Bob Olsson and has published in prestigious journals such as Molecular Psychiatry, Brain Behavior and Immunity and Psychiatry Research.

In The Last Decade

Anniella Isgren

12 papers receiving 361 citations

Peers

Anniella Isgren

PMH

Jeremias Schönherr Germany

Roberta Andrejew Brazil

Milica Borovčanin Serbia

Agnieszka Remlinger-Molenda Poland

Rubai Zhou China

Vanessa Fernandes Arnaud-Sampaio Brazil

Eszter Dömötör Hungary

R.B. Lu Taiwan

Zsófia Gál Hungary

Zan Wei Yang United States

Jeremias Schönherr Germany

Anniella Isgren

141 ×0.7

PMH

207 ×1.1

108 ×2.0

50 ×1.0

13 ×0.3

Citations per year, relative to Anniella Isgren Anniella Isgren (= 1×) peers Jeremias Schönherr

Countries citing papers authored by Anniella Isgren

Since Specialization

Citations

This map shows the geographic impact of Anniella Isgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anniella Isgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anniella Isgren more than expected).

Fields of papers citing papers by Anniella Isgren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anniella Isgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anniella Isgren. The network helps show where Anniella Isgren may publish in the future.

Co-authorship network of co-authors of Anniella Isgren

This figure shows the co-authorship network connecting the top 25 collaborators of Anniella Isgren. A scholar is included among the top collaborators of Anniella Isgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anniella Isgren. Anniella Isgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Koskuvi, Marja, Anniella Isgren, Helena Fatouros‐Bergman, et al.. (2024). Lower complement C1q levels in first-episode psychosis and in schizophrenia. Brain Behavior and Immunity. 117. 313–319. 2 indexed citations

Isgren, Anniella, Jessica Holmén‐Larsson, Carl M. Sellgren, et al.. (2022). Cerebrospinal fluid proteomic study of two bipolar disorder cohorts. Molecular Psychiatry. 27(11). 4568–4574. 11 indexed citations

Isgren, Anniella, Timea Sparding, Jessica Holmén‐Larsson, et al.. (2022). A serum proteomic study of two case-control cohorts identifies novel biomarkers for bipolar disorder. Translational Psychiatry. 12(1). 55–55. 13 indexed citations

Isgren, Anniella, Lina Jönsson, Timea Sparding, et al.. (2021). Cerebrospinal fluid proteomics targeted for central nervous system processes in bipolar disorder. Molecular Psychiatry. 26(12). 7446–7453. 15 indexed citations

Zhang, Ruyue, Jie Song, Anniella Isgren, et al.. (2020). Genome-wide study of immune biomarkers in cerebrospinal fluid and serum from patients with bipolar disorder and controls. Translational Psychiatry. 10(1). 58–58. 10 indexed citations

Cremaschi, Laura, Mathias Kardell, Viktoria Johansson, et al.. (2017). Prevalences of autoimmune diseases in schizophrenia, bipolar I and II disorder, and controls. Psychiatry Research. 258. 9–14. 38 indexed citations

Isgren, Anniella, Carl M. Sellgren, Jessica Holmén‐Larsson, et al.. (2017). Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes. Brain Behavior and Immunity. 65. 195–201. 71 indexed citations

Bergen, Sarah E., Erik Pålsson, Anniella Isgren, et al.. (2017). Genetic Influences On Inflammatory Biomarkers In Bipolar Disorder. European Neuropsychopharmacology. 27. S483–S484.

Kardell, Mathias, et al.. (2017). [Prescribed drug use for bipolar disorder type I and II in clinical practice].. PubMed. 114. 1 indexed citations

10.

Rolstad, Sindre, Joel Jakobsson, Carl M. Sellgren, et al.. (2015). CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment. European Neuropsychopharmacology. 25(8). 1091–1098. 44 indexed citations

11.

Jakobsson, Joel, Maria Bjerke, Anniella Isgren, et al.. (2015). Monocyte and microglial activation in patients with mood-stabilized bipolar disorder. Journal of Psychiatry and Neuroscience. 40(4). 250–258. 77 indexed citations

12.

Isgren, Anniella, Joel Jakobsson, Erik Pålsson, et al.. (2014). Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment. Brain Behavior and Immunity. 43. 198–204. 55 indexed citations

13.

Isgren, Anniella, et al.. (2011). High Survivin Levels Predict Poor Clinical Response to Infliximab Treatment in Patients with Rheumatoid Arthritis. Seminars in Arthritis and Rheumatism. 41(5). 652–657. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact